A detailed history of Ensign Peak Advisors, Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 208,302 shares of PTCT stock, worth $7.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
208,302
Previous 27,741 650.88%
Holding current value
$7.84 Million
Previous $806,000 690.2%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$24.69 - $40.12 $4.46 Million - $7.24 Million
180,561 Added 650.88%
208,302 $6.37 Million
Q1 2024

May 14, 2024

SELL
$24.15 - $31.95 $33,785 - $44,698
-1,399 Reduced 4.8%
27,741 $806,000
Q1 2023

May 15, 2023

SELL
$38.16 - $48.86 $6 Million - $7.68 Million
-157,110 Reduced 84.35%
29,140 $1.41 Million
Q4 2022

Feb 13, 2023

BUY
$33.53 - $54.79 $5.67 Million - $9.26 Million
169,010 Added 980.34%
186,250 $7.11 Million
Q3 2022

Nov 14, 2022

BUY
$41.85 - $53.85 $60,682 - $78,082
1,450 Added 9.18%
17,240 $865,000
Q2 2022

Aug 12, 2022

BUY
$25.6 - $45.23 $109,312 - $193,132
4,270 Added 37.07%
15,790 $633,000
Q1 2022

May 16, 2022

BUY
$33.33 - $44.6 $50,661 - $67,792
1,520 Added 15.2%
11,520 $430,000
Q4 2021

Feb 11, 2022

BUY
$35.36 - $41.86 $122,840 - $145,421
3,474 Added 53.23%
10,000 $398,000
Q3 2021

Nov 12, 2021

SELL
$37.01 - $44.74 $445,674 - $538,759
-12,042 Reduced 64.85%
6,526 $243,000
Q1 2021

May 12, 2021

SELL
$46.8 - $68.92 $1.72 Million - $2.53 Million
-36,757 Reduced 66.44%
18,568 $879,000
Q4 2020

Feb 12, 2021

BUY
$47.96 - $67.64 $1.26 Million - $1.77 Million
26,175 Added 89.79%
55,325 $3.38 Million
Q3 2020

Nov 12, 2020

BUY
$45.41 - $57.07 $1.03 Million - $1.29 Million
22,576 Added 343.41%
29,150 $1.36 Million
Q1 2020

May 11, 2020

SELL
$32.37 - $59.36 $330,950 - $606,896
-10,224 Reduced 60.86%
6,574 $293,000
Q4 2019

Feb 14, 2020

BUY
$32.22 - $50.07 $541,231 - $841,075
16,798 New
16,798 $806,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.69B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.